Dynavax Technologies Corp (NASDAQ:DVAX)

18.08
Delayed Data
As of Apr 20
 -0.62 / -3.34%
Today’s Change
5.15
Today|||52-Week Range
24.45
-3.34%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close18.70
Today’s open18.60
Day’s range17.80 - 18.73
Volume1,292,675
Average volume (3 months)1,519,806
Market cap$1.1B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+38.01%
Earnings growth (this year)+5.94%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.04%
P/E ratioNM
Price/Sales3,008.76
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA-0.34-1.13%
XNCRXencor Inc+0.18+0.61%
DERMDermira Inc+0.31+3.60%
AIMTAimmune Therapeutics...+0.30+0.96%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 7, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$327.0K
Annual profit (last year)-$95.2M
Net profit margin-29,099.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts